Our data show significantly increased levels of FPP and GGPP in brain tissue of AD patients as shown in Fig. 3B. On the other hand as noted in Fig. 5, cholesterol levels and gene expression of HMG-CoA reductase were similar in AD and control samples. This evidence concerns the gene HMGCR and Alzheimer disease.